Inari Medical Q1 revenue $143.2M (+23% YoY); raises FY2024 guidance, GAAP net loss widens to $24.2M

Inari Medical, Inc.

2024-Q1 EPS reported -$0.42 revenue$143,194,000

Revenue $143.2M, up 23.3% YoY; gross margin 86.8% (down from 88.2% prior year).
GAAP operating loss $17.2M vs $5.3M loss in Q1 2023; net loss $24.2M ($0.42 loss per share).
Non-GAAP operating loss $5.6M, excluding $6.3M contingent consideration, $2.8M acquisition costs, $2.5M amortization.
Raises FY2024 revenue guidance to $592.5M-$602.5M (from $580M-$595M); expects sustained profitability in H1 2025.
PEERLESS study on track for H2 2024; growth driven by commercial expansion and new products.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Inari Medical, Inc. reported first quarter ended March 31, 2024 results: revenue $143.2 million, net income Net loss was $24.2 million, EPS net loss per share was $0.42. Guidance raised.

Period: first quarter ended March 31, 2024
Revenue: $143.2 million
Net income: Net loss was $24.2 million
EPS: net loss per share was $0.42
Guidance: raised
Result: reported results

Exact text from the filing

and other diseases, today reported financial results for its first quarter ended March 31, 2024. First Quarter Financial and Recent Business Highlights • Generated revenue of $143.2 million in Q1 of 2024, up 23.3% over the same quarter last year. • GAAP operating loss was $17.2 million in Q1 of 2024, compared to a $5.3 million operating loss in the same quarter of

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001531048-24-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.